Pharma

PillPack, the mail-order pharmacy that raised $50 million last June, has finally gone mobile, launching its first app, for iOS and Apple Watch.

Last month, Roche quietly launched its Accu-Chek Connect app, a diabetes management app which contains, among other things, an unprecented feature: a prescription insulin bolus calculator called Bolus Advisor.

According to an SEC filing, mail-order personal genome service and research company 23andMe has raised $79 million, in a round the company hopes will top out at $150 million.

Novartis has released a new Apple Watch and Android Wear app geared at helping visually-impaired people navigate their environment.

A small study of veterans with epilepsy, conducted by PatientsLikeMe and sponsored by pharmaceutical company UCB, shows that an online patient community can increase self-efficacy and self-management of patients.

Pfizer Head of Clinical Innovation Craig Lipset In 2011, Pfizer announced a novel clinical trial that would be fully remote, with every aspect of the trial being handled either online, over the phone, or by mail.

Innovation in digital health won’t come in a gradual, incremental way, but rather through dramatic re-imaginings of care.

McNeil Consumer Healthcare, the Johnson & Johnson subsidiary that makes over the counter medications like Tylenol and Zyrtec, has released a new mobile app, called Healthyday, that uses crowdsourced data to inform users about location-based allergy, cold, and flu trends.

While Teladoc has been pulling in a lot of press lately with its IPO news, competitor American Well has been busy too, securing an eight-figure investment from Israeli pharmaceutical giant Teva, according to a recent report in Israeli publication Globes.

San Diego, California-based Companion Medical, a stealthy medical device startup developing a Bluetooth-connected insulin pen and connected app, has closed its second round of funding, led by Eli Lilly and Company.